Neuroendocrine tumours (NETs) comprise a heterogeneous group of neoplasms with very
varying clinical expression. A functioning NET, for instance in the pancreas, may be very …

Pancreatic neuroendocrine tumors (PNETs) are very rare, accounting for 1-2% of all
pancreatic neoplasms. They are classified into functioning and non-functioning and their …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of
neoplasms that arise from cells of the diffuse neuroendocrine system and are characterized …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) comprise a
heterogeneous group of neoplasms, which derive from cells of the diffuse neuroendocrine …

Detection of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and monitoring of
treatment response relies mainly on morphological imaging such as computed tomography …

Neuroendocrine tumours (NETs) constitute a heterogeneous group of tumours that are able
to express cell membrane neuroamine uptake mechanisms and/or specific receptors, such …

Imaging of gastroenteropancreatic neuroendocrine tumors can be broadly divided into
anatomic and functional techniques. Anatomic imaging determines the local extent of the …

Nuclear medicine plays a pivotal role in the imaging and treatment of neuroendocrine
tumours (NETs). Somatostatin receptor scintigraphy (SRS) with [111 In-DTPA 0] octreotide …

Neuroendocrine tumours (NETs) are rare, heterogeneous, and often hormonally active
neoplasms. Nuclear medicine (NM) imaging using single photon-and positron-emitting …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are relatively rare and
heterogenous malignancies. Recent advances in histopathological classification according …